Related Experiment Video
Updated: Jun 27, 2025

High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
Published on: April 21, 2022
The Role of SARS-CoV-2 Spike Protein in the Growth of Cervical Cancer Cells
Conner M Willson1, Marco Lequio2, Ziwen Zhu2
1Department of Microbiology, Immunology & Pathology, Des Moines University, Des Moines, IA, U.S.A.
Background/Aim:
Recently developed vaccines for the SARS-CoV-2 virus utilize endogenous production of the virus' spike protein (SP), allowing the host to develop an immune response. As a result of the novelty of this virus and its vaccines, little is known overall about the potential effects of the SP on the pathogenesis of neoplasia, either from vaccination or from infection. This study was designed to investigate whether SARS-CoV-2 SP has any direct effect on SiHa cervical cancer cells.
Materials And Methods:
The effects of SARS-CoV-2 SP on cervical cancer cell proliferation and apoptosis were investigated by using clonogenic cell survival assay, quick cell proliferation assay, and caspase-3 activity kits in a widely-used cervical cancer cell line, SiHa. RT-PCR and immunohistochemistry were also performed to determine the potential molecular mechanisms.
Results:
The growth and proliferation of SiHa cancer cells were inhibited by SARS-CoV-2 SP. SARS-CoV-2 SP also induced apoptosis in SiHa cancer cells. The anti-proliferative effect of SARS-CoV-2 SP on SiHa cancer cells was associated with the up-regulation of the anti-proliferative molecule p53. The pro-apoptotic effect of SARS-CoV-2 SP on SiHa cells was associated with the up-regulation of the pro-apoptotic molecule TRAIL.
Conclusion:
SARS-CoV-2 SP inhibits the growth of cervical cancer via up-regulation of p53 and TRAIL. Further studies are needed to elaborate on the potential effects of the SARS-CoV-2 SP on other cancer cell lines and normal physiological cell lines for comparison.
Insights
SARS-CoV-2 spike protein inhibits cervical cancer cell growth and induces apoptosis. This effect is linked to increased p53 and TRAIL expression, suggesting potential therapeutic avenues for cancer treatment.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- The SARS-CoV-2 spike protein (SP) is central to vaccines and infection, but its role in cancer pathogenesis is largely unknown.
- Understanding SP's direct effects on neoplasia is crucial given its widespread exposure through vaccination and infection.
Purpose of the Study:
- To investigate the direct impact of SARS-CoV-2 spike protein (SP) on SiHa cervical cancer cells.
- To determine if SP influences cancer cell proliferation and apoptosis.
Main Methods:
- Utilized clonogenic cell survival and quick proliferation assays to assess cell growth.
- Employed caspase-3 activity kits to measure apoptosis induction.
- Conducted RT-PCR and immunohistochemistry to explore underlying molecular mechanisms.
Main Results:
- SARS-CoV-2 SP significantly inhibited the proliferation of SiHa cervical cancer cells.
- SP treatment led to increased apoptosis in SiHa cells.
- Observed up-regulation of p53 (anti-proliferative) and TRAIL (pro-apoptotic) molecules.
Conclusions:
- SARS-CoV-2 SP demonstrates anti-cancer properties against cervical cancer cells by promoting apoptosis and inhibiting growth.
- The observed effects are mediated through the up-regulation of p53 and TRAIL.
- Further research is warranted to explore SP's effects on diverse cancer and normal cell types.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mitogens and the Cell Cycle
Cancer
Intracellular Movement of Viruses and Bacteria
Mechanisms of Retrovirus-induced Cancers
The Ras Gene
Ras is a...

